JPMorgan cuts Incyte stake by 46% amid mixed analyst ratings and insider sales.

JPMorgan Chase reduced its holdings in Incyte Corporation by 46.2% in Q3, selling over 384,000 shares. Despite this, other institutional investors increased their stakes, reflecting mixed confidence. Analyst ratings on Incyte vary, with some lowering price targets and others maintaining buy ratings. Insider sales also occurred, signaling cautious sentiment. Incyte reported solid revenue growth but missed EPS estimates, with a current consensus rating of 'Hold' and a target price around $103.44.